PD 116779
PD 116779 is an Antibiotic with anticancer activity. PD 116779 demonstrates moderate cytotoxicity against L1210 lymphocytic leukemia and HCT-8 human colon adenocarcinoma cell lines with IC50 values of 3.55x10-7 and 4.08x10-7 M, respectively[1].
Product Specifications
CAS Number
102674-89-5
UNSPSC
12352005
Target
Antibiotic
Type
Reference compound
Related Pathways
Anti-infection
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pd-116779.html
Smiles
O=C1C2=C(C[C@@](O)([C@H]1O)C)C=CC(C(C3=C(O)C=CC=C34)=O)=C2C4=O
Molecular Formula
C19H14O6
Molecular Weight
338.31
References & Citations
[1]Kern DL, et al. PD 116,779, a new antitumor antibiotic of the benz[a]anthraquinone class. J Antibiot (Tokyo) . 1986 Mar;39 (3) :469-70.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1369468-01 0.02 mg (E-Coli)
Recombinant Rhizobium loti Hydroxyacylglutathione hydrolase (gloB)
Sign In for Pricing
View Details MBS1369468-02 0.02 mg (Yeast)
Recombinant Rhizobium loti Hydroxyacylglutathione hydrolase (gloB)
Sign In for Pricing
View Details MBS1369468-03 0.1 mg (E-Coli)
Recombinant Rhizobium loti Hydroxyacylglutathione hydrolase (gloB)
Sign In for Pricing
View Details